Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/25/25 20:47 | 8/21/25 | CLDI | Health | BioPrd | Biological Products, (No Diag | Schoeneck James A | CA | D | 1 | P.d | 150 | 2.00 | 0 | 75 | 788 | 85 | D | |||||||||||||||
8/25/25 20:47 | 8/21/25 | CLDI | Health | BioPrd | Biological Products, (No Diag | Poma Eric E | CA | DO | CEO | 1 | P.d | 50 | 2.00 | 0 | 25 | 25 | D | |||||||||||||||
8/25/25 20:47 | 8/21/25 | CLDI | Health | BioPrd | Biological Products, (No Diag | Leftwich Scott | CA | D | 1 | P.d | 250 | 2.00 | 0 | 125 | 578 | 147 | D | |||||||||||||||
8/25/25 20:47 | 8/21/25 | CLDI | Health | BioPrd | Biological Products, (No Diag | Jackson Andrew C. | CA | O | CFO | 1 | P.d | 5 | 2.00 | 0 | 3 | 3 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |